OAI Classification for Sun Pharma Halol
In September 2025, the USFDA classified Sun Pharmaceutical Industries Ltd.’s Halol facility as OAI (Official
Warning letters, 483s, Recalls, Import Alerts, Audit observations
In September 2025, the USFDA classified Sun Pharmaceutical Industries Ltd.’s Halol facility as OAI (Official
Five different facilities of Eugia across India and US were inspected by USFDA between December
The Eugia facility in Bhiwadi, Rajasthan, India (FEI 3009883410) was recently classified as OAI (Official
Zydus Jarod facility (FEI 3013712903) is classified OAI by USFDA in July 2024. The USFDA
The USFDA issued a Warning Letter to the Chinese API manufacturer Chengdu KeCheng Fine Chemicals
In a communique Biocon stated USFDA has categorised inspection classification for Biocon Malaysia as OAI